Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Heinrichs
R Walter
RW
Department of Psychology, York University, Toronto, Ontario M3J 1P3, Canada. walterh@yorku.ca
D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D006801:Humans; D009483:Neuropsychological Tests / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
D014150:Antipsychotic Agents